 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 11904 | 回復(fù): 22 | |||||||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||||||
saliand新蟲(chóng) (初入文壇)
|
[交流]
諾華上海研發(fā)中心招聘
|
||||||
China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR) has some job vacancies as below. If you have interested in these jobs, please send your resume with no hesitation cause we'll provide you more chance to promote yourself in your field. (Sr.) Investigator, Medicinal Chemistry Investigator, Bioinformatics Investigator II/III, Hair Cell Investigator, Epigenetics of Cancer Drug Discovery Investigator, Developmental Biology Scientist I/II, Cellular Assays Investigator, Computer-Aided Drug Design Clinical Trial Head Head of Scientific Operations For more details, please click our career website: http://careers.novartis.com.cn/vacancies.html To apply this position, please send your resume to sarah.qi@novartis.com When you send your resume to sarah.qi@novartis.com, please notice you know this position information via 小木蟲(chóng)BBS 諾華（中國(guó)）生物醫(yī)學(xué)研究有限公司是諾華全球研發(fā)組織――諾華生物醫(yī)學(xué)研究所（NIBR）的第八個(gè)研究基地。我們位于中國(guó)上海市張江高科技園區(qū)，將成為諾華在亞洲的主要研究中心，以及除在歐美的研究中心外的最主要的研究中心。我們的研究和探索開(kāi)發(fā)活動(dòng)的重點(diǎn)是發(fā)現(xiàn)并開(kāi)發(fā)創(chuàng)新療法，用于治療在亞洲遠(yuǎn)未達(dá)到醫(yī)藥需求的疾病。我們與從不同之處在于將專注現(xiàn)代藥物的發(fā)現(xiàn)和開(kāi)發(fā)方法的研究。最初階段，研發(fā)工作將專注在引起中國(guó)地方性癌癥的感染原因。我們還將開(kāi)展臨床試驗(yàn)，進(jìn)行安全性研究，生物標(biāo)志物和檢測(cè)分析，表達(dá)譜、生物分析以及轉(zhuǎn)化醫(yī)學(xué)的研究。 隨著公司業(yè)務(wù)的迅速擴(kuò)展，我們熱忱歡迎您的加入。同時(shí)我們將提供具有競(jìng)爭(zhēng)力的薪酬福利待遇以及良好的培訓(xùn)發(fā)展機(jī)會(huì)。 NIBR Shanghai NIBR Shanghai is an integrated research center that is part of the Novartis global research and development network. The establishment of this strategic site is a commitment by Novartis to conduct cutting-edge pharmaceutical research in China. Research activities at NIBR Shanghai focus on addressing urgent medical needs in China, particularly infectious causes of cancer endemic to the region. The center also established programs in epigenetics, biomarker development, drug metabolism and preclinical safety to support NIBR local and global R&D projects.Research at NIBR Shanghai is currently focused on discovering new therapies for infectious causes of cancer, such as liver cancer caused by HBV or HCV hepatitis. As the diseases are highly prevalent in the region, some one-third of the 400 million people infected with the hepatitis B virus are in China, with estimates that 300,000 people die from liver cancer in the mainland each year. A Growing and Dynamic Organization China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR), the legal entity for NIBR Research Center in Shanghai was launched in November 2006 and the start-up Research facilities opened in April 2007. Today, NIBR Shanghai has grown to an organization of about 260 associates including nearly 200 scientists. The research teams are comprised of both returnee scientists from abroad (about 20% of total scientists), and graduates from top tier universities, medical centers, and research institutes in China. Currently the center operates in an office building and two lab facilities in the Zhangjiang Hi-Tech Park. In the same area, the new Novartis Shanghai Campus is under design and construction. The first phase of the project will be completed by the end of 2014. [ Last edited by saliand on 2013-8-7 at 15:17 ] Investigator II Job Purpose Manage projects (with a TA focus), interpret and present information and negotiate an optimal PK/PD strategy for early and late development in liaison with TA-PK Head and appropriate line functions. Responsible for the PK, PK/PD and M&S component of study protocols, reports and project summaries within agreed timeframes and which meet regulatory requirements. Take the lead on appropriate pharmacokinetic /biopharmaceutical studies. Major Accountabilities • Define PK, PK/PD, biopharmaceutical and M&S requirements in project (nonclinical and clinical) development plans and appropriate strategies for global registration. • Analyze, interpret and represent PK, PK/PD and M&S data generated during development and provide guidance. • Proactively manage links with other functions to ensure that pre-clinical and clinical PK/PD information are used optimally. • Directly or indirectly take the lead on appropriate pharmacokinetic/biopharmaceutical studies. • Prepare summary information for internal and external Advisory panels, Investigator meetings and Health Authorities as part of the regulatory approval process. This includes PK/PD components of IND applications in the US, CTX in other countries. • Represent the PK/PD discipline and ensure high quality interactions with various health authorities, external investigators, and various internal Novartis Disease Area experts • Coordinate with appropriate sub-team members and other LF experts and/ or prepare (when needed) summary documentation on drug metabolism and pharmacokinetics as required by ethics committees and HAs (IB, BB, CTA/IND, responses to HAs). • Prepare, compile and review appropriate sections of CTD dossiers /NDA documents. • Contribute to and support continuous improvement initiatives in global pharmacokinetics and partner functions Ideal Background Education: Ph.D. in Pharmaceutical Sciences, or related disciplines (or equivalent degree/knowledge/expertise) Languages: fluent English and Chinese (spoken and written) Experience: 3-4 years of experiences in drug development or a relevant environment [ Last edited by saliand on 2013-10-12 at 17:49 ] |
回復(fù)此樓» 猜你喜歡
0856，材料與化工321分求調(diào)劑
已經(jīng)有6人回復(fù)
-
0703化學(xué)求調(diào)劑，各位老師看看我�。�！
已經(jīng)有5人回復(fù)
-
266分，求材料冶金能源化工等調(diào)劑
已經(jīng)有7人回復(fù)
-
張芳銘-中國(guó)農(nóng)業(yè)大學(xué)-環(huán)境工程專碩-298
已經(jīng)有3人回復(fù)
-
070300化學(xué)求調(diào)劑
已經(jīng)有4人回復(fù)
-
086000調(diào)劑
已經(jīng)有3人回復(fù)
-
320分，材料與化工專業(yè)，求調(diào)劑
已經(jīng)有4人回復(fù)
-
265求調(diào)劑
已經(jīng)有7人回復(fù)
-
295材料工程專碩求調(diào)劑
已經(jīng)有4人回復(fù)
-
高溫高壓反應(yīng)求助
已經(jīng)有4人回復(fù)
saliand
新蟲(chóng) (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 3.5
- 帖子: 15
- 在線: 55分鐘
- 蟲(chóng)號(hào): 2516050
- 注冊(cè): 2013-06-21
|
Scientist I/II, Cellular Assays Job Purpose We are seeking an energetic, motivated scientist to join CNIBR to support drug discovery research in the epigenetics areas. A person in this role must be enthusiastic to contribute and share responsibilities with team members for biochemical and cell-based assay development and regular running. In addition, he/she will also be involved in epigenome profiling and mechanism studies on the specific epigenetic targets. Under the supervision of a senior scientist, the successful candidate is expected to work independently to execute, interpret and troubleshoot experiments. The successful candidate will also participate in multi- disciplinary drug discovery and develop all-around skills in the disease areas of focus in the long run. Minimum requirements • A MS degree in life science and 1+ years of drug discovery experience, or a PhD degree in Biological Science with proven record of accomplishment are necessary. • Experience with multiple cell based methods (Cell culture, RNAi technology, cell growth/proliferation assays, western blot, immunofluorescence, ELISA, real-time PCR) are required. Prior experience with small molecules handling and medium to high throughput screening are desired. Good understanding of enzymology is a plus. • The candidate must be highly self-motivated and have good communication skills to work in a collaborative team environment. Excellent writing and presentation skills, with good multi-tasking ability are needed. • Competences in maintaining lab notebooks and computer files are also required. |
7樓2013-07-30 17:31:38
saliand
新蟲(chóng) (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 3.5
- 帖子: 15
- 在線: 55分鐘
- 蟲(chóng)號(hào): 2516050
- 注冊(cè): 2013-06-21
|
Investigator II/III, Hair Cell Job Description: Explore the molecular mechanism underlying inner ear hair cell development and regeneration Elucidate the molecular mechanism of hair cell differentiation and transdifferentiation, genetic and epigenetic regulation of hair cell development and regeneration Minimum requirements: Ph.D. in Developmental Biology, Cell Biology or related fields or a Medical degree in Otolaryngology, minimal three years postdoc training Strong scientific capabilities as manifested by a strong publication record Previous experience in hearing research is required. Deep understanding of hair cell biology, particularly hair cell development and regeneration as well as hands on experience with primary tissue culture, organotypical culture, small animal surgery and molecular biology are required |
2樓2013-07-30 17:14:24
saliand
新蟲(chóng) (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 3.5
- 帖子: 15
- 在線: 55分鐘
- 蟲(chóng)號(hào): 2516050
- 注冊(cè): 2013-06-21
|
Sr. Investigator, Medicinal Chemistry Job Description: Lead a group of medicinal scientists (Ph.D./MS) to support drug discovery research programs Design tool compounds and experiments to support target validity, drive hits to high quality leads and drug candidates by optimization of efficacy, ADME and safety Collaborate with scientists from other platforms in Novartis and external collaborators Minimum Requirements: Ph.D. in synthetic organic or medicinal chemistry; > 5 years of relevant experience in the major pharmaceutical industry or biotechs Experience in identifying hits for difficult targets by exploiting in silico methods, novel chemical libraries and structure based design, oncology and immunology experience as required Proven track record of innovative project contributions including peer-reviewed publications Ability to work independently and ability to collaborate with a multidisciplinary team, excellent oral/written communication and presentation skills [ Last edited by saliand on 2013-7-30 at 17:21 ] |
3樓2013-07-30 17:19:58
saliand
新蟲(chóng) (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 3.5
- 帖子: 15
- 在線: 55分鐘
- 蟲(chóng)號(hào): 2516050
- 注冊(cè): 2013-06-21
|
Investigator, Bioinformatics Job Description: Data mining of large scale multi-omics data Integrating multi-omics data for drug discovery and biomarker development Developing useful computational tools and new algorithms for biological research Providing expert data-mining support to drug discovery and translational research Minimum requirements: Ph.D. in bioinformatics, computational biology, mathematics, computer science or other related fields Three or more years of relevant post-graduate research experience in bioinformatics data analysis Independent problem-solving capability Excellent skills in statistical software like R and/or Matlab Excellent programming skills with scripting language such as Perl and Python Experience with next-generation-sequencing data is essential Wide experience in genome-sequencing, ChIP-seq, transcriptomics, and proteomics, compound profiling analysis |
4樓2013-07-30 17:22:52
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[有機(jī)交流]
高溫高壓反應(yīng)求助
 10+4
|
chibby 2026-03-25 | 4/200 |
|
|---|---|---|---|---|
|
|
[考研] 295求調(diào)劑 +4 | 1428151015 2026-03-27 | 5/250 |
|
|
[考博] 26申博 +3 | 加油沖��！ 2026-03-26 | 3/150 |
|
|
|
[考研] 081200-11408-276學(xué)碩求調(diào)劑 +3 | 崔wj 2026-03-26 | 3/150 |
|
|
|
[碩博家園] 招收生物學(xué)/細(xì)胞生物學(xué)調(diào)劑 +3 | IceGuo 2026-03-26 | 4/200 |
|
|
|
[考研] 071000生物學(xué)求調(diào)劑，初試成績(jī)343 +6 | 小小甜面團(tuán) 2026-03-25 | 6/300 |
|
|
|
[考研] 材料與化工304求B區(qū)調(diào)劑 +3 | 邱gl 2026-03-26 | 6/300 |
|
|
|
[考研]
 085602化學(xué)工程求調(diào)劑。
+4
|
平樂(lè)樂(lè)樂(lè) 2026-03-26 | 4/200 |
|
|
|
[考研] 299求調(diào)劑 +4 | 15188958825 2026-03-25 | 4/200 |
|
|
|
[考研] 【2026考研調(diào)劑】制藥工程 284分 求相關(guān)專業(yè)調(diào)劑名額 +4 | 袁奐奐 2026-03-25 | 8/400 |
|
|
|
[考研] 0854電子信息求調(diào)劑 +7 | α____ 2026-03-22 | 9/450 |
|
|
|
[考研] 318求調(diào)劑 +3 | plum李子 2026-03-23 | 3/150 |
|
|
|
[考研] 化學(xué)調(diào)劑 +6 | yzysaa 2026-03-21 | 6/300 |
|
|
|
[考研] 一志愿南航材料專317分求調(diào)劑 +5 | 炸呀炸呀炸薯?xiàng)l 2026-03-23 | 5/250 |
|
|
|
[基金申請(qǐng)] 請(qǐng)教下大家 2026年國(guó)家基金申請(qǐng)是雙盲審嗎？ +3 | lishucheng1 2026-03-22 | 5/250 |
|
|
|
[考研] 284求調(diào)劑 +3 | yanzhixue111 2026-03-23 | 6/300 |
|
|
|
[考研] 生物學(xué)調(diào)劑 +5 | Surekei 2026-03-21 | 5/250 |
|
|
|
[考研] 材料學(xué)碩301分求調(diào)劑 +7 | Liyouyumairs 2026-03-21 | 7/350 |
|
|
|
[考研] 0703化學(xué)調(diào)劑 +4 | 妮妮ninicgb 2026-03-21 | 4/200 |
|
|
|
[考研] 330求調(diào)劑0854 +3 | assdll 2026-03-21 | 3/150 |
|